Responses
Original article
Frequency of the TMPRSS2:ERG gene fusion is increased in moderate to poorly differentiated prostate cancers
Compose a Response to This Article
Other responses
Jump to comment:
- Published on: 18 April 2016
- Published on: 18 April 2016TMPRSS2-ERG in Localized Parostate CancerShow More
Dear Editor
The TMPRSS2-ERG has been described in several prostate cancer patients' cohorts. The article by Ashish et al. describes the frequency of this fusion in another patient cohort. It further demonstrates that the frequency of TMPRSS2-ERG is increased in moderate to poorly differentiated tumors. We would like to congratulate the authors on their interesting study and advocate that more work still has to be carrie...
Conflict of Interest:
None declared.